185 related articles for article (PubMed ID: 33722889)
21. Activity of Omadacycline in Rat Methicillin-Resistant Staphylococcus aureus Osteomyelitis.
Karau MJ; Schmidt-Malan SM; Cunningham SA; Mandrekar JN; Pritt BS; Keepers TR; Serio AW; Chitra S; Patel R
Antimicrob Agents Chemother; 2022 Jan; 66(1):e0170321. PubMed ID: 34723626
[TBL] [Abstract][Full Text] [Related]
22. Methicillin-resistant Staphylococcus aureus infections: role of daptomycin/β-lactams combination.
Leone S; Noviello S; Boccia G; De Caro F; Esposito S
Infez Med; 2015 Jun; 23(2):99-104. PubMed ID: 26110289
[TBL] [Abstract][Full Text] [Related]
23. Telavancin in therapy of experimental aortic valve endocarditis in rabbits due to daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus.
Xiong YQ; Hady WA; Bayer AS; Chen L; Kreiswirth BN; Yang SJ
Antimicrob Agents Chemother; 2012 Nov; 56(11):5528-33. PubMed ID: 22890759
[TBL] [Abstract][Full Text] [Related]
24. Daptomycin-nonsusceptible vancomycin-intermediate staphylococcus aureus vertebral osteomyelitis cases complicated by bacteremia treated with high-dose daptomycin and trimethoprim-sulfamethoxazole.
Avery LM; Steed ME; Woodruff AE; Hasan M; Rybak MJ
Antimicrob Agents Chemother; 2012 Nov; 56(11):5990-3. PubMed ID: 22869580
[TBL] [Abstract][Full Text] [Related]
25. Daptomycin in bone and joint infections: a review of the literature.
Rice DA; Mendez-Vigo L
Arch Orthop Trauma Surg; 2009 Nov; 129(11):1495-504. PubMed ID: 18989686
[TBL] [Abstract][Full Text] [Related]
26. Variable daptomycin susceptibility in patients receiving intravenous vancomycin for meticillin-resistant Staphylococcus aureus infections.
Golden M; Shaib W; Havill N
Int J Antimicrob Agents; 2010 Mar; 35(3):306-8. PubMed ID: 20036108
[No Abstract] [Full Text] [Related]
27. Addition of daptomycin to levofloxacin increased the efficacy of levofloxacin monotherapy against a methicillin-susceptible
Cottagnoud P; Sprenker F; Cottagnoud M; Collaud A; Ashkbus R; Perreten V
J Med Microbiol; 2022 Feb; 71(2):. PubMed ID: 35108179
[No Abstract] [Full Text] [Related]
28. Development of Daptomycin resistance in vivo in methicillin-resistant Staphylococcus aureus.
Hayden MK; Rezai K; Hayes RA; Lolans K; Quinn JP; Weinstein RA
J Clin Microbiol; 2005 Oct; 43(10):5285-7. PubMed ID: 16207998
[TBL] [Abstract][Full Text] [Related]
29. Daptomycin versus vancomycin in treatment of methicillin-resistant Staphylococcus aureus meningitis in an experimental rabbit model.
Bardak-Ozcem S; Turhan T; Sipahi OR; Arda B; Pullukcu H; Yamazhan T; Isikgoz-Tasbakan M; Sipahi H; Ulusoy S
Antimicrob Agents Chemother; 2013 Mar; 57(3):1556-8. PubMed ID: 23318792
[TBL] [Abstract][Full Text] [Related]
30. The use of daptomycin for Staphylococcus aureus infections in critical care medicine.
Alder J
Crit Care Clin; 2008 Apr; 24(2):349-63, ix-x. PubMed ID: 18361950
[TBL] [Abstract][Full Text] [Related]
31. [Daptomycin for the treatment of infective endocarditis: When do we use it?].
Şimşek Yavuz S
Turk Kardiyol Dern Ars; 2017 Jun; 45(4):303-307. PubMed ID: 28595198
[No Abstract] [Full Text] [Related]
32. Emergence of resistance to daptomycin in a cohort of patients with methicillin-resistant Staphylococcus aureus persistent bacteraemia treated with daptomycin.
Gasch O; Camoez M; Domínguez MA; Padilla B; Pintado V; Almirante B; Martín C; López-Medrano F; de Gopegui ER; Blanco JR; García-Pardo G; Calbo E; Montero M; Granados A; Jover A; Dueñas C; Pujol M;
J Antimicrob Chemother; 2014 Feb; 69(2):568-71. PubMed ID: 24107389
[No Abstract] [Full Text] [Related]
33. Comparative evaluation of daptomycin (LY146032) and vancomycin in the treatment of experimental methicillin-resistant Staphylococcus aureus osteomyelitis in rabbits.
Mader JT; Adams K
Antimicrob Agents Chemother; 1989 May; 33(5):689-92. PubMed ID: 2546488
[TBL] [Abstract][Full Text] [Related]
34. Combination therapy with lysin CF-301 and antibiotic is superior to antibiotic alone for treating methicillin-resistant Staphylococcus aureus-induced murine bacteremia.
Schuch R; Lee HM; Schneider BC; Sauve KL; Law C; Khan BK; Rotolo JA; Horiuchi Y; Couto DE; Raz A; Fischetti VA; Huang DB; Nowinski RC; Wittekind M
J Infect Dis; 2014 May; 209(9):1469-78. PubMed ID: 24286983
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of fosfomycin in experimental osteomyelitis due to methicillin-resistant Staphylococcus aureus.
Poeppl W; Tobudic S; Lingscheid T; Plasenzotti R; Kozakowski N; Georgopoulos A; Burgmann H
Antimicrob Agents Chemother; 2011 Feb; 55(2):931-3. PubMed ID: 21098253
[TBL] [Abstract][Full Text] [Related]
36. Methicillin-resistant Staphylococcus aureus infection with intermediate sensitivity to vancomycin: a case report and literature review.
Schairer J; Sankri-Tarbichi AG; Fairfax MR; Salimnia H; Guzman JA
J Intensive Care Med; 2008; 23(5):338-41. PubMed ID: 18701528
[TBL] [Abstract][Full Text] [Related]
37. In vivo efficacy of daptomycin against methicillin-resistant Staphylococcus aureus in a mouse model of hematogenous pulmonary infection.
Harada Y; Yanagihara K; Yamada K; Migiyama Y; Nagaoka K; Morinaga Y; Nakamura S; Imamura Y; Hasegawa H; Miyazaki T; Izumikawa K; Kakeya H; Kohno S
Antimicrob Agents Chemother; 2013 Jun; 57(6):2841-4. PubMed ID: 23507279
[TBL] [Abstract][Full Text] [Related]
38. Considerations about the Use of a Loading Dose of Daptomycin in a Neutropenic Murine Thigh Infection Model with Methicillin-Resistant Staphylococcus aureus Infection.
Kato H; Hagihara M; Murakami E; Suematsu H; Nishiyama N; Koizumi Y; Yamagishi Y; Uno B; Mikamo H
Chemotherapy; 2018; 63(1):13-19. PubMed ID: 29130946
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of Nanoencapsulated Daptomycin in an Experimental Methicillin-Resistant Staphylococcus aureus Bone and Joint Infection Model.
Jacqueline C; Caillon J; Meyer O; Dailly E; Simonsson C; Lenaerts V; Asehnoune K; Reghal A; Potel G
Antimicrob Agents Chemother; 2021 Nov; 65(12):e0076821. PubMed ID: 34606337
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of daptomycin-cloxacillin combination in experimental foreign-body infection due to methicillin-resistant Staphylococcus aureus.
Garrigós C; Murillo O; Lora-Tamayo J; Verdaguer R; Tubau F; Cabellos C; Cabo J; Ariza J
Antimicrob Agents Chemother; 2012 Jul; 56(7):3806-11. PubMed ID: 22585211
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
